Statement of the Problem: Recurrent aphthous stomatitis (RAS) is the most prevalent ulcerative condition of the oral mucosa. Many studies have emphasized on immunologic factors as the reason of inducing RAS; however, the exact etiologic cause of RAS has not been identified yet. Vitamin D has an endocrine function and regulatory effects on the immune system. It has potential therapeutic effects on autoimmune diseases, psoriasis, and neoplasms. Vitamin D deficiency has been detected in some autoimmune diseases such as rheumatoid arteritis.
Introduction
Recurrent aphthous stomatitis (RAS) is the most common ulcerative condition of the oral cavity mucosa, which is characterized by round and painful ulcers with an erythematous area surrounding the ulcers. The central areas of the ulcers are covered with a yellowishbrown pseudo membrane. [1] [2] Generally, RAS appears with a burning sensation 2-48 hours before the ulcers appear on the buccal and labial mucosa and on the tongue. Involvement of the keratinized areas of the oral cavity such as the mucosa of the palate and gingiva is less common. [1] [2] [3] Numerous factors such as trauma and microbial cell-mediated immune reactions. [8] [9] An imbalance has been reported in the immune system of patients with RAS compared to healthy individuals. [10] Vitamin D has an endocrine function on immune system cells and is responsible for anti-inflammatory reactions and regulatory effects on the immune system. [11] In addition, it has potential therapeutic effects on autoimmune diseases, psoriasis, and neoplasms. [12] The basic mechanisms for the role of vitamin D in autoimmune diseases are still not very clear. Its deficiency has been reported in some autoimmune diseases such as rheumatoid arteritis, systemic lupus erythematosus, Type I diabetes mellitus, multiple sclerosis, inflammatory diseases of the intestine, thyroid autoimmune diseases (such as Hashimoto and Graves diseases), and autoimmune gastritis. [11] [12] Salivary test is a laboratory diagnostic test for identification of hormonal, immunologic, inflammatory, and infectious markers. Steroid hormones such as cortisol, genetic markers, and proteins such as enzymes and antibiotics are secreted into the saliva and can be measured. Several studies have reported similarities between the concentrations of some markers in the saliva and serum and some of these markers can be measured as diagnostic laboratory tests. [13] [14] [15] Collecting venous blood sample is the most commonly used technique for the evaluation of blood markers. However, collecting venous blood sample and its transportation carries the risk of contamination. In addition, collecting salivary samples is a non-invasive technique and is easily accepted by patients. [13] [14] Considering the relationship between some of these markers in the saliva and serum and since there were no studies evaluating the salivary vitamin D levels in patients with RAS up to date, the present study was conducted to determine and compare salivary and serum levels of vitamin D in patients with RAS and healthy individuals.
Materials and Method
The protocol of the current cross sectional study was Data were analyzed with independent samples ttest, using SPSS 17. Statistical significance was set at p< 0.05.
Results
The mean age of the subjects was 39.80±11.74 years, with mean ages of 38.80±12.02 (an age range of 21-58 years) and 40.80±11.60 (an age range of 22-55 years) in the case and control groups, respectively. Based on the results of independent t-test, there was no statistically significant difference between the mean age of the two groups (p= 0.54, CI=-8.58 to 4.58).
33(63.5%) individuals were male and 19(36.5%) individuals were female. 16(61.5%) and 17(65.4%) individuals were male and 10(38.5%) and 9(34.6%) were female in the case and control groups, respectively. Based on the results of independent t-test, there was a 3-unit difference in the mean of salivary vitamin D levels between the subjects with RAS and the healthy controls, with a higher level in healthy controls; however, the difference was not statistically significant (p= 0.09, CI= -7.447 to 0.587).
Pearson's correlation coefficient was used to evaluate the correlation of salivary and serum levels of vitamin D in subject with RAS and healthy controls. The correlation was reported to be 56%, which was significant (p<0.001). Considering the positivity of Pearson's correlation coefficient and the significant of level of min D increased with an increase in its serum level.
Discussion
Based on the results, there was no significant difference in mean age and gender between case and control groups. Since age and gender can be considered as a factor affecting the serum and salivary levels of vitamin D, the absence of a significant difference between the two groups might be considered as the absence of the effect of age and gender on measurements. The mean serum level of vitamin D in the healthy controls was higher than that in patients' group and it was statistically significant. This finding is consistent with the results of similar studies, which have shown that the serum levels of vitamin D in RAS patients were less than that in healthy individuals. Khabbazi et al. [16] showed that patients with RAS exhibited lower vitamin D serum levels compared to healthy individuals. A similar study by Lalla et al. [17] showed that treatment with multivitamin, compared to placebo, resulted in a significant decrease in the number of RAS attacks.
On the other hand, the relationship between the serum levels of vitamin D and other autoimmune diseases indicates the important role of this vitamin in the prevention of such conditions. For example, in the study enrolled by Khabbazi et al., [18] the results showed that the mean serum level of vitamin D in patients with Behçet's disease was lower than that in control individuals. In addition, vitamin D deficiency was more prevalent in patients compared to healthy controls. [18] Hamzaoul et al., [19] have also reported a lower serum level of vitamin D in patients with Behçet's disease compared to healthy individuals. In addition, subjects with active Behçet's disease exhibited a lower serum level of vitamin D compared to those with inactive Behçet's disease. [19] In a study conducted by Watad et al., [20] the serum levels of vitamin D in patients with lupus were lower than that in healthy controls. Vondra [21] represented that vitamin D deficiency can be considered as one of the risk factors for autoimmune thyroiditis. Stagi et al., [22] reported the vitamin D levels in patients with PFAPA syndrome were significantly lower than the control group. In addition, following vitamin D replacement in case group, there was a significant decrease in disease symptoms and signs. [22] There Karincaoglu et al. [27] determined and compared the salivary and serum levels of antioxidative enzymes in patients with RAS and healthy controls and reported no significant difference in the salivary concentrations of these enzymes, including superoxide dismutase and catalase.
In a different study performed by Saral et al., [28] the serum levels of antioxidative vitamins (A, C and E) RAS. The serum and salivary levels of vitamins A, C and E were lower in patients with RAS compared to healthy controls. The serum and salivary levels of malodialdehyde (MDA) was significantly higher in patients with RAS compared to healthy controls [28] . Aziz et al. [9] determined the total salivary capacity of antioxidants in patients with RAS and reported no significant differences between the patients with RAS and healthy individuals.
Numerous factors such as trauma, microbial The results of such studies might help prevent and find new treatment modalities with the use of vitamin D supplements so that the antioxidative system in patients with RAS can be strengthened.
Conclusion
The serum levels of vitamin D in subjects with RAS were significantly less than that in healthy individuals.
There was a significant and positive correlation between vitamin D serum and salivary levels. There were no significant differences in salivary vitamin D levels between patients with RAS and healthy individuals.
